Novavax Inc (NVAX)

Finanzdaten der Novavax Inc-Aktie (NVAX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	59.36%56.70	139.51	147.14	70.45	239.24
Cost Of Revenue	53.59%14.25	30.70	22.10	21.50	15.33
	7.34%26.67	28.78	-	-	-
Selling, General, and Administrative	7.34%26.67	28.78	-	-	-
Research and Development	25.95%70.69	95.47	-	-	-
Costs And Expenses	27.97%111.60	154.94	132.91	248.46	138.17
Depreciation and Amortization	0.20%3.06	3.06	5.13	6.59	7.56
Operating Income/Loss	255.84%-54.91	-15.43	14.23	-178.02	101.07
Income/Loss From Continuing Operations Before Tax	507.52%-51.68	-8.51	17.90	-203.04	107.45
Income Tax Expense/Benefit	73.71%1.71	0.99	0.38	-0.66	0.95
	462.50%-53.39	-9.49	17.53	-202.38	106.51
Attributable To Parent	462.50%-53.39	-9.49	17.53	-202.38	106.51
Available To Common Stockholders, Basic	462.50%-53.39	-9.49	17.53	-202.38	106.51
Basic Average Shares	0.79%164.57	163.28	0.18	162.35	162.02
Diluted Average Shares	0.79%164.57	163.28	4.91	162.35	177.22
Basic Earnings Per Share	433.33%-0.32	-0.06	0.11	-1.25	0.66
Diluted Earnings Per Share	433.33%-0.32	-0.06	0.05	-1.25	0.62